95
Views
6
CrossRef citations to date
0
Altmetric
Articles

Sesamol Upregulates Death Receptors and Acts as a Chemosensitizer in Solid Ehrlich Carcinoma Model in Mice

, , , &
Pages 250-264 | Received 23 Jun 2020, Accepted 19 Dec 2020, Published online: 13 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jiayi Xiong, Juanjuan Sheng, Yan Wei, Zhimin Sun, Xia Xiao & Lanmei Zhang. (2022) Sesamol Augments Paclitaxel-Induced Apoptosis in Human Cervical Cancer Cell Lines. Nutrition and Cancer 74:10, pages 3692-3700.
Read now

Articles from other publishers (5)

Amira M. Othman, Noha Abdel-Rahman, May Denewer & Laila A. Eissa. (2023) Sinapic acid and 3,3′-diindolylmethane potentiate cyclophosphamide antitumor activity through induction of apoptosis and inhibition of metastasis. International Immunopharmacology 118, pages 110074.
Crossref
Nesma A. Abd Elrazik, Mohamed El-Mesery & Mamdouh M. El-Shishtawy. (2022) Sesamol protects against liver fibrosis induced in rats by modulating lysophosphatidic acid receptor expression and TGF-β/Smad3 signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 395:8, pages 1003-1016.
Crossref
D Ezhilarasan, D Ali & R Varghese. (2021) Sesamol induces cytotoxicity via mitochondrial apoptosis in SCC-25 cells. Human & Experimental Toxicology 40:12_suppl, pages S423-S433.
Crossref
Yousra M. El‐Far & Mohamed El‐Mesery. (2021) Pevonedistat attenuates cisplatin‐induced nephrotoxicity in mice by downregulating the release of inflammatory mediators. Journal of Biochemical and Molecular Toxicology 35:11.
Crossref
Nada F. Abo El‐Magd, Mohamed El‐Mesery, Amro El‐Karef & Mamdouh M. El‐Shishtawy. (2021) Amelioration effect of black seed oil against high‐fat diet‐induced obesity in rats through Nrf2/HO‐1 pathway. Journal of Food Biochemistry 45:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.